2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | 6.974 | 7.013 | 0 | 325.044 | 332.216 | 135.589 | 0 | 0 | 0 |
Total Income - EUR | - | 6.974 | 7.013 | 0 | 325.125 | 332.457 | 135.589 | 59 | 6.236 | 0 |
Total Expenses - EUR | - | 703 | 4.264 | 26.090 | 367.573 | 391.158 | 154.080 | 5.783 | 3.882 | 583 |
Gross Profit/Loss - EUR | - | 6.271 | 2.749 | -26.090 | -42.448 | -58.701 | -18.490 | -5.724 | 2.354 | -583 |
Net Profit/Loss - EUR | - | 6.061 | 2.608 | -26.090 | -45.700 | -58.701 | -18.490 | -5.724 | 2.354 | -583 |
Employees | - | 1 | 1 | 2 | 5 | 5 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Sepharma S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | 127 | 0 | 5.567 | 18.172 | 13.182 | 8.224 | 3.516 | 2.543 | 2.022 |
Current Assets | - | 8.151 | 8.733 | 7.308 | 60.754 | 33.617 | 13.983 | 13.688 | 17.068 | 16.946 |
Inventories | - | 0 | 0 | 2.627 | 5.637 | 22.259 | 2.682 | 2.623 | 0 | 0 |
Receivables | - | 0 | 55 | 3.766 | 52.651 | 10.508 | 11.120 | 383 | 818 | 815 |
Cash | - | 8.151 | 8.678 | 915 | 2.466 | 849 | 181 | 10.681 | 16.250 | 16.131 |
Shareholders Funds | - | 6.106 | 8.652 | -25.652 | -60.566 | -118.095 | -134.346 | -137.091 | -135.163 | -135.336 |
Social Capital | - | 45 | 45 | 438 | 10.745 | 10.537 | 10.337 | 10.108 | 10.139 | 10.108 |
Debts | - | 2.171 | 80 | 38.527 | 139.492 | 164.893 | 156.554 | 154.294 | 154.773 | 154.304 |
Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4646 - 4646" | |||||||||
CAEN Financial Year |
4646
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Sepharma S.r.l.